Source: www.dentaleconomics.com Author: staff LED Dental has announced a recent study suggests that its VELscope screening system can help surgeons reduce the recurrence rate for oral cancer following surgery. The article, “Tracing the ‘At-Risk’ Oral Mucosa Field with Autofluorescence: Steps Toward Clinical Impact,” was just published in the journal, Cancer Prevention Research. The article was was authored [...]
Continue reading...Tuesday, December 8, 2009
Source: www.eurekalert.org Author: public release Eighteen single-point genetic variations indicate risk of recurrence for early-stage head and neck cancer patients and their likelihood of developing a second type of cancer, researchers at The University of Texas M. D. Anderson Cancer Center reported at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference. The team [...]
Continue reading...Saturday, November 28, 2009
Source: Arch Otolaryngol Head Neck Surg, November 1, 2009; 135(11) Authors: JJ Jaber et al. Objective: To determine the recurrence and survival outcome based on treatment date, type of treatment, stage of disease, and comorbidity and the recurrence and survival differences based on smoking status as a surrogate for human papillomavirus status in veterans treated for tonsillar squamous [...]
Continue reading...Tuesday, August 18, 2009
Source: www.medicalnewstoday.com Author: staff Patients with head and neck cancer who experience a higher level of post-treatment pain appear to have a lower survival rate than those who experience little or no post-treatment pain, according to a report in the August issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals. “Pain is an [...]
Continue reading...Sunday, July 26, 2009
Source: www.prweb.com Author: press release LED Dental Inc. announced today that a recent study suggests that its VELscope screening system can help surgeons reduce the recurrence rate for oral cancer following surgery. The article, “Tracing the ‘At-Risk’ Oral Mucosa Field with Autofluorescence: Steps Toward Clinical Impact,” was just published in the journal Cancer Prevention Research. It was [...]
Continue reading...Friday, July 3, 2009
Source: J Oral Pathol Med, June 25, 2009 Authors: S R Larsen et al. Background: Different factors predict nodal metastasis, recurrence and survival in oral cancer. The aim was to assess the prognostic value of histological features related to the primary tumour. Methods: A total of 144 patients surgically treated at Odense University Hospital for oral cancer between [...]
Continue reading...Sunday, December 28, 2008
Source: American Association for Cancer Research Author: staff A study published in the journal Clinical Cancer Research, a journal of the American Association for Cancer Research, validates a non-invasive screening method with future potential for detection of human papillomavirus (HPV)-positive head and neck cancers. In the study, researchers at Johns Hopkins University used oral rinses and targeted DNA [...]
Continue reading...Sunday, November 16, 2008
Source: Clin Otolaryngol, August 1, 2008; 33(4): 331-7 Authors: V Paleri and CG Kelly Objectives: Local recurrence is the major cause of treatment failure in head and neck cancer patients after radiation or combined therapy. If surgically unresectable, management involves supportive care or chemotherapy with palliative intent. Recent studies have assessed the role of re-irradiating these patients with [...]
Continue reading...Thursday, September 25, 2008
Source: CURE Magazine (www.curetoday.com) Author: Kathy LaTour When Julia Rowland, PhD, director of the Office of Cancer Survivorship at the National Cancer Institute, took the stage in Atlanta at the fourth biennial cancer survivorship research conference in June, she welcomed the more than 450 participants on behalf of the estimated 12 million cancer survivors in the country [...]
Continue reading...Friday, August 1, 2008
Source: Abkhazia (www.abkhazia.com) Author: Ramaz Mitaishvili In patients with locally recurrent carcinomas of the oral cavity and oropharynx, a disease-free interval of more than 1 year and tumor tissue negative for EGFR (epidermal growth factor receptor) expression predict a good response to salvage surgery. That’s the conclusion of physicians in Brazil who studied the outcomes of 111 patients [...]
Continue reading...
Thursday, February 18, 2010
0 Comments